期刊文献+

雷帕霉素栓剂的制备及质量评价 被引量:3

Preparation and quality evaluation of rapamycin suppository
下载PDF
导出
摘要 目的:制备一种含雷帕霉素的聚乙二醇栓剂,并对其质量进行评价。方法:以雷帕霉素为原料药,聚乙二醇2000和聚乙二醇4000为主要基质,热熔法工艺制备含药栓剂,并对其药物含量、重量差异、融变时限、药物溶出等进行评价。结果:雷帕霉素聚乙二醇栓剂外观呈白色半透明状,室温下保持较好的硬度,药物含量、重量差异和融变时限均符合栓剂要求,药物在释放介质中约25 min释放达到75%以上。结论:本研究制备的雷帕霉素聚乙二醇栓剂符合中国药典栓剂质量检测要求,有望开发成雷帕霉素的一种新剂型。 Objective: To prepare rapamycin suppository, and to evaluate its quality. Methods: Rapamycinwas used as active ingredient, polyethylene glycol 2000 and polyethylene glycol 4000 were used as main substrates. The suppositories were made using hot melt process method, and the drug content, weight difference, melting time, drug release with time were evaluated. Results: Polyethylene glycol suppository with rapamycin appeared white and translucent. Good hardness could be maintained at room temperature. The drug content, weight varia- tion and melting time limit matched the requirements for the suppository. More than 75% of the loaded drug in the suppositories was released at about 25 min in the medium. Conclusion: This preparation of rapamycin polyeth- ylene glycol (PEG) suppository can reach the quality requirements of Chinese pharmacopoeia, and may be developed as a new formulation of rapamycin.
出处 《温州医学院学报》 CAS 2014年第2期148-150,共3页 Journal of Wenzhou Medical College
基金 国家自然科学基金资助项目(81071277) 浙江省自然科学基金资助项目(Y2080915) 义乌市科技攻关项目(13-3-28)
关键词 雷帕霉素 聚乙二醇 栓剂 质量评价 rapamycin polyethylene glycol suppository quality evaluation
  • 相关文献

参考文献7

  • 1Soleimani AR, Kamkar 1, Nikoueinejad H, et al. Comparison of cyclosporine and sirolimus effects on serum creatinine level over five years after kidney transplantation[J]. Trans- plant Proc, 2013, 45(4): 1644-1647. 被引量:1
  • 2Flechner SM, Gurkan A, Hartmann A, et al. A randomized, open-label study of sirolimus versus vyclosporine in pri- mary de novo renal allograft recipients[J]. Transplant- ation, 2013, 95(10): 1233-1241. 被引量:1
  • 3崔福德.药剂学[M].北京:人民卫生出版社,2011:96. 被引量:32
  • 4魏静,徐国旭,龚铠,盛敏杰,林安娟.雷帕霉素眼膏的制备及其含量测定[J].中国现代医药杂志,2010,12(6):11-14. 被引量:7
  • 5刘春艳..尼美舒利栓剂和中空栓剂研制及其药代动力学[D].河北医科大学,2003:
  • 6Kauss T, Gaubert A, Boyer C, et al. Pharmaceutical develop- ment and optimization of azithromycin suppository for paediatric use[J]. Int J Pharm, 2013, 441(1-2): 218-226. 被引量:1
  • 7国家药典委员会编..中华人民共和国药典[M].北京:化学工业出版社,2002:135.

二级参考文献8

  • 1Slavik JM,Lim DG,Burakoff SJ,et al.Uncoupling p70(s6) kinase activation and proliferation;rapamycin-resistant proliferation of human CD8(+)T lymphocytes.J Immunol[J].2001,166(5):3201-3209. 被引量:1
  • 2Kitagawa H,Hotta Y,Fujiki K,et al.Cloning and high expression of rabbit FKBP25 in cornea.Jpn J Ophthalmol[J].1996,40(2):133-141. 被引量:1
  • 3Mohaupt MG,Vogt B,Freg FJ.Sirolimu sassociated eyelid edema in kidney transplant recipients.Transplantation[J] ,2001,72 (1):162-164. 被引量:1
  • 4Bertelmann E,Pleyer U.Immunomodulatory therapy in ophthalmo-1 ogy-is there a place for topical application? Ophthalmology[J] ,2003,100(12):1036-1044. 被引量:1
  • 5中国药典委员会.中国药典第二部[S].2000(附录):332. 被引量:1
  • 6Chang K,Sehgal SN.Pharmacology of rapamycin:a new immunosuppressive agent.Br J Rheumatol[J].1991,30:62-65. 被引量:1
  • 7D.W.Holt,D.A.McKeown,T.D.Lee,et al.The Relative Proportions of Sirolimus Metabolites in Blood Using HPLC With MassSpectrometric Detection.Transplantation Proceedings[J] ,2004,36:3223-3225. 被引量:1
  • 8傅茜,任斌,刘敏,王长希,陈立中,曾文涛.微粒子酶联免疫方法和高效液相色谱法测定肾移植受者雷帕霉素血药浓度的比较[J].中国医院药学杂志,2009,29(1):41-43. 被引量:3

共引文献37

同被引文献19

  • 1许明哲,尹利辉,胡昌勤.HPLC法测定他克莫司软膏剂含量及含量均匀度[J].中国抗生素杂志,2005,30(12):748-751. 被引量:16
  • 2王英.HPLC法测定他克莫司片的含量[J].海峡药学,2007,19(6):49-51. 被引量:5
  • 3崔福德.药剂学[M] .7版.北京:人民卫生出版社,2011:197-198. 被引量:46
  • 4Morice MC,Serruys PW,Sousa JE,et al.A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization[J].N Engl J Med,2002,346(23):1 773. 被引量:1
  • 5Asrani SK,Wiesner RH,Trotter JF,et al.De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation:the 2000-2003 ph-aseⅡprospective randomized trial[J].Am J Transplant,2014,14(2):356. 被引量:1
  • 6Ceberio I,Devlin SM,Sauter C,et al.Sirolimus,tacrolimus and low-dose methotrexate based GVHD prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allo-HCT[J].Leuk Lymphoma,2014,6:1. 被引量:1
  • 7Niemann CU, Eilers H. Abdominal organ transplantation[J]. Minerva Anestesiol, 2010, 76(4): 266-275. 被引量:1
  • 8Wei X, Jiang H, Li Q. Organ transplantation in China not yet a new era[J]. Lancet, 2014, 384(9945):741. 被引量:1
  • 9Flechner SM, Gurkan A, Hartmann A, et al. A randomized, open-label study of sirolimus versus cyclosporine in primary de novo renal allograft recipients[J]. Transplantation, 2013, 95(10): 1233-1241. 被引量:1
  • 10Soleimani AR, Kamkar I, Nikoueinejad H, et al. Compari- son of cyclosporine and sirolimus effects on serum creatinine level over five years after kidney transplantation[J]. Transplant Proc, 2013, 45(4): 1644-1647. 被引量:1

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部